Patient-Reported and End-of-Life Outcomes Among Adults with Oncogene-Driven Lung Cancer in a Clinical Trial of Early Integrated Palliative Care: A Secondary Analysis (F415C)

Targeted therapy has revolutionized treatment for patients with oncogene-driven non-small cell lung cancer (NSCLC), though data are lacking on patient-reported and end-of-life (EOL) care outcomes in this population.

Source: Journal of Pain and Symptom Management - February 23, 2021 Category: Palliative Care Authors: Laura A. Petrillo, Areej El-Jawahri, Emily R. Gallagher, Vicki Jackson, Jennifer Temel, Joseph Greer Source Type: research